Ptc Therapeutics (PTCT) Goodwill & Intangibles (2017 - 2026)

Ptc Therapeutics' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $485.3 million for Q2 2026.

• In Q2 2026, Goodwill & Intangibles rose 114.58% year-over-year to $485.3 million; the TTM figure through Jun 2026 stood at $485.3 million (up 114.58% YoY), while the FY2025 annual figure was $471.1 million, up 134.22% from the prior year.
• Goodwill & Intangibles for Q2 2026 stood at $485.3 million, up from $463.0 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $846.0 million in Q1 2022, with the low at $200.8 million in Q1 2025.
• The 5-year median for Goodwill & Intangibles is $475.0 million (2025), against an average of $519.0 million.
• The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles plunged 56.45% in 2024, then soared 134.22% in 2025.
• Ptc Therapeutics' Goodwill & Intangibles stood at $788.2 million in 2022, then slumped by 41.41% to $461.8 million in 2023, then slumped by 56.45% to $201.1 million in 2024, then soared by 134.22% to $471.1 million in 2025, then advanced by 3.01% to $485.3 million in 2026.
• Business Quant data shows PTCT's Goodwill & Intangibles at $485.3 million in Q2 2026, $463.0 million in Q1 2026, and $471.1 million in Q4 2025.